Mobile handset maker Samsung is not happy with just churning out new phones. The company is making a play for a bigger position in the mobile ecosystem with the launch of a new platform.

Called Samsung bada, the platform will allow developers to create applications for more commonly used feature phones, says the company. To that effect, Samsung will offer developers a Software Development Kit (SDK) to program apps for the platform.

“By opening Samsung’s mobile platform, we will be able to provide rich mobile experiences on an increasing number of accessible phones,” says Hosoo Lee,  executive vice president at Samsung Electronics.

Details about bada are sketchy and Samsung hasn’t made it clear if bada–which means ‘ocean’ in Korean– will be a new mobile operating system based on a Linux kernel or if it will just be an extension of the company’s proprietary OS.

Samsung, also, did not offer any details on how the bada platform will fit into its existing app store. In August, Samsung launched a mobile app store for Europe.

With more than 60 million phones sold worldwide in the third quarter, Samsung is the second largest mobile handsets maker. But most of the company’s sales come from less expensive handsets known as feature phones. Currently all app stores are focused on powerful smartphones.

For software developers, bada’s SDK could offer an easy way to tap into the installed base of Samsung phones through native apps instead of using Java (for GSM phones) or BREW (for CDMA devices). Bada is expected to make its debut on Samsung phones in 2010.

See Also:

• Samsung’s Flexible OLED Screen Goes Under the Hammer
• Review: Samsung NC20
• Samsung Blue Earth Phone Made From Old Plastic Bottles
• Samsung Fields Green, Ultra-Slim LCD TVs

Photo: (Cyrillicus/Flickr)

I’ve reviewed the Droid Eris twice before, when it was called the Hero. The difference is that Verizon’s selling it for half the price, making it the cheapest Android phone you can buy—and the best, for the money.

Eris is Verizon’s other Droid phone. It really is a remodeled Hero, running Android 1.5 and HTC’s vaunted Sense candy coating—documented CSI style here—a $200 phone stuffed inside a thinner $100 body, like a Corvette engine shoved inside a Saturn. It’s admittedly less exciting than the titular Droid, an industrial beast running Android 2.0. But I have the feeling Verizon is gonna sell a lot more of these things, because, again, it’s $100.

Designing for the Middle of the Road

The Eris is rubbery blob, a narrow oval that’s as subdued as a phone could possibly be, but there is admittedly something comforting about the Eris’s utter lack of personality—it’s completely non-threatening, like a middle manager. It’s so generic it’s almost artful, actually, a design that is nearly perfect for a cheap phone.

The four main Android buttons are touch sensitive, bleeding into the black bezel, hovering over the dead-center trackball and hard chrome buttons for phone and end. I’d like a dedicated camera button, but a volume rocker is all we get. The camera lens stares out the back, disturbingly more reminiscent of an eye than most cameras sticking out the backs of phones, probably because of how stark the rest of the phone is.

Hardware and Camera

The actual guts and screen are the same as past Hero phones—which is to say, nearly the same as all of HTC’s other Android phones so far. The 480×320 screen’s still nice, even if it feels dated now that the Droid’s massive screen, beckoning the next generation, looms large over it. Oh yeah, HTC? Can you get rid of your stupid, pointlessly different version of the mini USB port? Let’s go to micro USB now, yeah?

The still camera’s better than the Droid though, and about the same as the Sprint version of the Hero, performing pretty decently in low-light situations. Video, not so much:

Software and the Endgame

I’ve already covered HTC’s Sense UI in depth, and it is the exact same on the Eris. It runs just as fast as the Sprint Hero, if not a teeny bit quicker. I will say that after using Android 2.0, it does feel like a step backward in some ways, mostly because of the single Google account limitation. But HTC’s confirmed Android 2.0 is coming, so it won’t be an issue for every long.

And really, the fact that Android 2.0—half the reason the Droid is excellent—is coming to the Droid Eris is why, in the end, it’s such a steal. It’s running on Verizon, it’s going to have Android 2.0, and it’s $100. It’s a great phone now, and will be better still soon, making it kind of a perfect storm for people on Verizon looking to ditch their dumbphones—but not Verizon—for something more capable, but who are put off by the Droid, whether it’s the steroids or the higher sticker price.

It’s last month’s darling. But it’ll run this month’s software. For cheap. And that’s pretty spiffy, actually.

You’re getting last month’s killer Android phone for half price


We’ll say it again: This is the best Android deal around


Android 1.5 feels a little dated


Video recording’s not exactly amazing

The PM Series Podcaster kit gives you mostly everything you need to start recording and producing your own podcasts.

In 2003, we mapped the human genome, the 20,000-ish genes we all share. It cost $3 billion. Today, you can literally spit in a cup, place the saliva in the mail and get a peek at your own.

Services like 23andMe (proponents of the above-mentioned “spit parties”) and Navigenics both examine specific snippets of your genome for known severe genetic conditions like diabetes, bipolar disorder and certain types of cancers (as well as goofier stuff like freckling and “food preference”).

Meanwhile, a boutique genome mapping company named Knome maps not just snippets of DNA but your entire genome, using a blood sample. When it’s ready, they sit you down with a doctor to explain their findings.

This thoroughness comes at a cost, of course. Knome’s service will run you the price of a Porsche, while their competitors bill up to only a thousand dollars, often less. And while we can technically map the entire genome, we certainly can’t understand everything we see.

Ari Kiirikki, a VP at Knome we met at TEDMED, decodes the future of genomics in this brief Q&A:

Where’s genomics now?

The first human genome, completed in 2003, took 13 years and nearly $3 billion to decode. Today, we can sequence and interpret an entire human genome in a matter of weeks for less than $70,000 (our current price is $68,000). New software and other analytical tools have put decades of accumulated scientific research at our fingertips, enabling us to analyze an individual’s DNA in order to identify risk for thousands of diseases and other inherited traits and conditions.

What will we be doing in 5 years?

Within 5 years, the cost of sequencing an entire human genome is expected to plummet below $1,000, which will dramatically increase the demand for genetic sequence interpretation. The resulting increase in raw data will enable scientists to make new and important discoveries linking our DNA to health and disease, thereby further increasing the clinical utility of DNA analysis. This will enable us to finally deliver on the promise of personalized medicine by allowing scientists to begin the development medicines and individualized “cocktails” of therapeutics tailored to individual genetic profiles.

In 10?

Ten years from now, sequencing a human genome will cost less than $100. Within the decade, scientists are likely to have unraveled precisely how DNA interacts with our environment to impact our risk for developing disease. Expect DNA sequencing to become a regular part of your annual check-up along with the introduction of new therapeutics that can be prescribed to help delay or completely avoid getting specific diseases that you may be predisposed to.

And now we’re stretching it, what about 20?

Every medicine you take will be tailored specifically to your genome. Every newborn child will be sequenced at birth, enabling future generations to use their DNA to guide the management of their health over their entire lifetime. Perhaps most amazingly, your DNA will be fully integrated into your everyday life. Genetics will move beyond the clinic, into a broad range of consumer products—snacks, vitamins, mouthwash, skin creams, dating services, etc., all optimized for your unique genetic profile.

I can’t speak for everyone here, but I could certainly go for a stick of gum that, instead of being labeled “grape” or “spearmint,” simply stated, “You’ll enjoy DNA-certified flavor, fatty.”

[Image: Human chromosomes “painted” by flourescent dyes to detect abnormal exchange of genetic material frequently present in cancer. Chromosome paints also serve as valuable resources for other clinical and research applications.

Human Genome Program, U.S. Department of Energy, Human Genome Program Report, 1997.]

This week, Gizmodo is exploring the enhanced human future in a segment we call This Cyborg Life. It’s about what happens when we treat our body less as a sacred object and more as what it is: Nature’s ultimate machine.

We’re still reserving our doubts about the viability of the enTourage eDGe — after all, at $490 you can buy yourself a respectable netbook and a halfway decent ereader for the appropriate occasion — but we won’t say that we’re not interested. Just under a month after it hit the scene, the dual-screen device has landed (in prototype form) over at Gearlog, and while some of the features weren’t functional, the physical build shouldn’t change much when it goes final. At first glance, the whole thing just looks a bit dated, but then again, we’ve still got the ultra-fresh Nook on the brain. Hit the read link to have a look yourself, won’t you?

Filed under: Displays, Handhelds

Dual-screen enTourage eDGe ebook reader gets a little hands-on time originally appeared on Engadget on Tue, 10 Nov 2009 14:58:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments